Department of Clinical Neurosciences, Western General Hospital, Edinburgh, EH4 2XU, UK.
Stroke. 2011 Jan;42(1):10-6. doi: 10.1161/STROKEAHA.110.588954. Epub 2010 Dec 2.
inflammatory markers may be associated with recurrent vascular events after stroke. We aimed to determine the association between IL-6, C-reactive protein, fibrinogen and white cell count, with recurrent vascular events after stroke, and to compare the association between circulating inflammatory markers with the risk of death from vascular vs nonvascular causes.
we prospectively recruited patients with acute stroke (n=817) and followed them for up to 4 years for the occurrence of fatal or nonfatal recurrent stroke, myocardial infarction or fatal vascular events, and death from any cause (n=159).
the delay to assessment was a median of 10 days. The adjusted incidence of the outcome cluster recurrent stroke, myocardial infarction or vascular death after stroke was significantly higher with higher levels of IL-6 (75(th) to 25(th) percentile hazard ratio, 1.56; 95% CI, 1.37-1.77), C-reactive protein (75(th) to 25(th) percentile hazard ratio, 1.08; 95% CI, 1.04-1.11), and fibrinogen (75(th) to 25(th) percentile hazard ratio, 1.45; 95% CI, 1.24-1.72). The associations between inflammatory markers and death were stronger than with recurrent vascular events. The associations of inflammatory markers with vascular and nonvascular deaths were similar.
although inflammatory markers were associated with an increased risk of recurrent vascular events and vascular death after stroke, they were also associated with nonvascular causes of death, suggesting that inflammatory markers do not play a causal role specifically in the generation of recurrent vascular events after stroke. Future studies of the prediction of recurrent vascular events after stroke should concentrate on clinical variables or different blood markers.
炎症标志物可能与卒中后复发性血管事件有关。我们旨在确定白细胞介素-6(IL-6)、C 反应蛋白(CRP)、纤维蛋白原和白细胞计数与卒中后复发性血管事件之间的关系,并比较循环炎症标志物与血管性和非血管性死亡风险之间的关系。
我们前瞻性招募了急性卒中患者(n=817),并在 4 年内对其进行随访,以确定致命或非致命性复发性卒中、心肌梗死或致命性血管事件以及任何原因所致死亡(n=159)的发生情况。
评估的延迟中位数为 10 天。IL-6(第 75 百分位数至第 25 百分位数的危险比为 1.56;95%可信区间为 1.37-1.77)、CRP(第 75 百分位数至第 25 百分位数的危险比为 1.08;95%可信区间为 1.04-1.11)和纤维蛋白原(第 75 百分位数至第 25 百分位数的危险比为 1.45;95%可信区间为 1.24-1.72)水平较高的患者发生卒中后复发性卒中、心肌梗死或血管性死亡的综合结局集群的校正发病率显著较高。炎症标志物与死亡的关联强于与复发性血管事件的关联。炎症标志物与血管性和非血管性死亡的关联相似。
尽管炎症标志物与卒中后复发性血管事件和血管性死亡的风险增加有关,但它们也与非血管性死亡原因有关,这表明炎症标志物在卒中后复发性血管事件的发生中并非起因果作用。未来对卒中后复发性血管事件的预测研究应集中于临床变量或不同的血液标志物。